Skip to main content
IH

Id Health

This health tech company provides personalized polypharmacy treatments for cardiometabolic diseases. Their platform optimizes drug combinations to enhance efficacy, minimize side effects, and reduce pharmaceutical waste, enabling healthcare professionals to deliver more effective and sustainable patient care.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

The traditional "one size fits all" approach to medicine often leads to ineffective treatments, adverse drug reactions, pharmaceutical waste, and increasing drug shortages. Healthcare practitioners lack the necessary tools, knowledge, and time to deliver personalized care according to clinical guidelines, resulting in trial-and-error drug dosing and limited communication between healthcare providers and patients.

Solution

ID Health provides a technology platform designed to unlock the market for personalized medicines and integrated care, enabling healthcare practitioners to deliver precision medicine at scale. The platform leverages manufacturing technology to create dose-personalized medicines made just-in-time within the market, ensuring the right drug and precise dosing for the right amount of time. By enabling asynchronous communication and continuous medication review leveraging data, ID Health aims to improve patient health outcomes and maximize resource efficiency.

Target Audience

The primary target audience includes healthcare practitioners seeking to deliver personalized care and health systems aiming to implement personalized medicine at scale.

Features

  • Core enabling manufacturing technology for dose-personalized medicine
  • Prescription for patients' dose-personalized medicine
  • Asynchronous communication between healthcare providers and patients
  • Continuous medication review leveraging data
This profile is AI-generated and may contain inaccuracies.